Publications by authors named "Eric Pujade-Lauraine"

113Publications

PARP Inhibitors in Ovarian Cancer. Reply.

N Engl J Med 2020 04;382(16):1574-1575

Université Paris Descartes, Paris, France.

View Article and Find Full Text PDF
April 2020

Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer.

N Engl J Med 2019 12;381(25):2416-2428

From Centre Léon Bérard (I.R.-C., D.P.), University Claude Bernard Lyon 1 (I.R.-C.), and Centre Hospitalier Lyon-Sud (B.Y.), Lyon, Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO) (I.R.-C., P.P., F.S., C.L.-P., A.L., P.C., M.R., C.D., B.Y., E.P.-L.), Groupe Hospitalier Diaconesses Croix Saint-Simon (F.S.), Hôpital Européen Georges Pompidou (P.C.), Institut Curie, Hôpital Claudius Régaud (M.R.), and Association de Recherche Cancers Gynécologiques (ARCAGY) (E.P.-L.), Paris, Gustave Roussy, Villejuif (P.P.), Centre Eugène Marquis, Rennes (C.L.-P.), Centre Catherine de Sienne Hôpital Privé du Confluent, Nantes (A.L.), and Institut Curie, Hôpital René Huguenin, Saint Cloud (C.D.) - all in France; the Department of Urology and Gynecology, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, and Multicenter Italian Trials in Ovarian Cancer and Gynecologic Malignancies (MITO), Naples (S.P.), University of Milan-Bicocca and European Institute of Oncology IRCCS, and Mario Negri Gynecologic Oncology Group (MANGO) (N.C.), and Fondazione IRCCS Istituto Nazionale Tumori and MITO (D.L.), Milan, and Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica, and MITO, Rome (G.S.) - all in Italy; M.D. Anderson Cancer Center Madrid (A.G.-M.), Grupo Español de Investigación en Cáncer de Ovario (GEICO) (A.G.-M., E.M.G.A.), and Hospital Universitario Ramón y Cajal (E.M.G.A.) - all in Madrid; Medical University of Innsbruck, University Clinic for Gynecology and Obstetrics (R.B.), and Arbeitsgemeinschaft Gynäkologische Onkologie Study Group (AGO)-Austria (R.B., A.R.), Innsbruck, and Medical University of Vienna, Vienna (A.R.) - all in Austria; Saitama Medical University International Medical Center, Hidaka (K.F.), Gynecologic Oncology Trial and Investigation Consortium (GOTIC), Moroyama-cho (K.F., S.N.), and Hyogo Cancer Center, Akashi (S.N.) - all in Japan; University Hospital Leuven, Leuven Cancer Institute, and Belgium and Luxembourg Gynecologic Oncology Group (BGOG) - both in Leuven, Belgium (I.V.); Tampere University and University Hospital, Tampere, Finland (J.M.); the Nordic Society of Gynecologic Oncology (NSGO), Copenhagen (J.M.); and Charité-Medical University of Berlin (Campus Virchow Klinikum), Berlin (J.S.), German Society of Gynecologic Oncology (AGO) (J.S., U.C., F.M., N.G., P.B., A.B., P.H.), Universitätsklinikum Essen (P.B.), and Kliniken Essen Mitte (P.H.), Essen, Universitätsklinikum Carl Gustav Carus, Technische Universität Dresden, Dresden (U.C.), Universitätsklinikum Heidelberg, Heidelberg (F.M.), Universitätsklinikum Ulm, Ulm (N.G.), and Klinikum der Universität München, Munich (A.B.) - all in Germany.

View Article and Find Full Text PDF
December 2019

Progress and Promise in Treating Gynecologic Cancers.

J Clin Oncol 2019 09 12;37(27):2383-2385. Epub 2019 Aug 12.

Association of Research on Cancers Including Gynecological-Group of National Investigators for the Study of Ovarian and Breast Cancers, Paris, France.

View Article and Find Full Text PDF
September 2019

Management of Platinum-Resistant, Relapsed Epithelial Ovarian Cancer and New Drug Perspectives.

J Clin Oncol 2019 09 12;37(27):2437-2448. Epub 2019 Aug 12.

Istituto Nazionale Tumori Fondazione G Pascale, Istituto di Ricovero e Cura a Carattere Scientifico, Napoli, Italy.

View Article and Find Full Text PDF
September 2019

Advances in the Management of Platinum-Sensitive Relapsed Ovarian Cancer.

J Clin Oncol 2019 09 12;37(27):2424-2436. Epub 2019 Aug 12.

Beth Israel Medical Center and Harvard Medical School, Boston, MA.

View Article and Find Full Text PDF
September 2019

Olaparib as maintenance treatment for patients with platinum-sensitive relapsed ovarian cancer.

Ther Adv Med Oncol 2019 22;11:1758835919849753. Epub 2019 May 22.

Hôpital Hôtel-Dieu, Université Paris Descartes, Paris, France.

View Article and Find Full Text PDF
May 2019

Prognostic impact of initial tumor load and intraperitoneal disease dissemination patterns in patients with advanced ovarian cancer undergoing complete cytoreductive surgery.

Eur J Surg Oncol 2019 Sep 17;45(9):1619-1624. Epub 2019 Apr 17.

Department of Breast and Gynecological Surgical Oncology, Hôpital Européen Georges Pompidou, AP-HP, Paris, France; Paris-Descartes University, Sorbonne Paris Cité, Paris, France. Electronic address:

View Article and Find Full Text PDF
September 2019

Early treatment modifications improve chemotherapy adherence in ovarian cancer patients ≥70 years.

Gynecol Oncol 2019 06 21;153(3):616-624. Epub 2019 Mar 21.

Department of Gynecology and Obstetrics, University Hospital Schleswig-Holstein, Kiel, Germany; Onkologisches Therapiezentrum, Krankenhaus Jerusalem, Hamburg, Germany.

View Article and Find Full Text PDF
June 2019

High Expression of HLA-G in Ovarian Carcinomatosis: The Role of Interleukin-1β.

Neoplasia 2019 03 22;21(3):331-342. Epub 2019 Feb 22.

INSERM U965, Sorbonne Paris Cité-Paris Diderot University, Carcinomatosis Angiogenesis Translational Research, Hospital Lariboisière, 75010 Paris, France. Electronic address:

View Article and Find Full Text PDF
March 2019